Palpant Group

IMB researchers have teamed up to develop precise, personalised drugs for epilepsy patients

The first-ever drug to treat heart attack and protect donor hearts will now move to human clinical trials

A molecule sourced from funnel web spider venom shows promise as a safe and effective drug for heart attacks.

IMB has a winner and two finalists in this year's Women in Technology Awards.

Enakshi Sinniah is exploring the untapped powers of DNA to discover what influences and causes heart disease.

A potentially life-saving treatment containing venom from one of the world’s deadliest spiders is one step closer to human trials, thanks to a $23 million investment in a Brisbane start-up.

It might be one of the most feared arachnids in the world, but research shows the deadly funnel web spider could make the difference between life and death for heart attack victims. 

A potentially life-saving treatment - Hi1a - for heart attack victims has been discovered from the venom of the Fraser Island funnel web spider.